Fresenius SE & Co. KGaA Share Price Other OTC
Equities
FSNUY
US35804M1053
Healthcare Facilities & Services
Sales 2024 * | 22.96B 24.47B 2,046B | Sales 2025 * | 24.06B 25.65B 2,144B | Capitalization | 15.75B 16.79B 1,404B |
---|---|---|---|---|---|
Net income 2024 * | 1.45B 1.55B 129B | Net income 2025 * | 1.78B 1.9B 159B | EV / Sales 2024 * | 1.31 x |
Net Debt 2024 * | 14.27B 15.21B 1,272B | Net Debt 2025 * | 13.48B 14.37B 1,201B | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
8.78
x | Employees | - |
Yield 2024 * |
3.34% | Yield 2025 * |
3.79% | Free-Float | 73.04% |
Latest transcript on Fresenius SE & Co. KGaA
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 12/21/12 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 01/19/01 |
Michael Moser
CMP | Compliance Officer | - | 18/23/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 20/15/20 |
Wolfgang Kirsch
CHM | Chairman | 69 | 01/20/01 |
Director/Board Member | 63 | 13/16/13 |
1st Jan change | Capi. | |
---|---|---|
-14.25% | 85.02B | |
+14.46% | 82.37B | |
+9.37% | 29.29B | |
-11.40% | 17.21B | |
+0.22% | 15.5B | |
+4.32% | 12.15B | |
-2.34% | 12.13B | |
+32.69% | 12.12B | |
-31.05% | 11.8B |